The involvement of RCAS1 in creating a suppressive tumor microenvironment in patients with salivary gland adenocarcinoma

Cancer Microenvironment

Volumn 4, Issue 1, 2011, Pages 13-21

  Dutsch Wicherek, Magdalena ^a   Lazar, Agata ^a   Tomaszewska, Romana ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

RCAS1 positive macrophages; Salivary gland adenocarcinoma; Tumor microenvironment

Indexed keywords

BIOLOGICAL MARKER; CD3 ANTIGEN; CD68 ANTIGEN; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; RCAS1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MACROPHAGE; MALE; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; SCHOOL CHILD; STROMA; TUMOR MICROENVIRONMENT;

EID: 79952534403     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-010-0051-6     Document Type: Article

References (45)

1. IP Witz 2009 The tumor microenvironment: the making of a paradigm Cancer Microenvironment 2 S9 S17 10.1007/s12307-009-0025-8
2. I Kryczek L Zou P Rodriguez G Zhu S Wei P Mottram M Brumlik P Cheng T Curie L Myers A Lackner X Alvarez A Ochoa L Chen W Zou 2007 B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma JEM 203 871 881
3. W Zou 2005 Immunosuppressive networks in the tumor microenvironment and their therapeutic relevance Nat Rev Cancer 5 263 274 15776005 10.1038/nrc1586 1:CAS:528:DC%2BD2MXivVars7g%3D (Pubitemid 40488632)
4. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D (Pubitemid 36019639)
5. K Sonoda M Nakashima T Kaku T Kamura H Nakano T Watanabe 1996 A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas Cancer 77 1501 1509 8608535 10.1002/(SICI)1097-0142(19960415)77:8<1501::AID- CNCR12>3.0.CO;2-3 1:CAS:528:DyaK28XislKgu70%3D (Pubitemid 26105386)
6. K Sonoda S Miyamoto T Hirakawa H Yagi F Yotsumoto M Nakashima T Watanabe H Nakano 2006 Clinical significance of RCAS1 as a biomarker of uterine cancer Gynecol Oncol 103 924 931 16842844 10.1016/j.ygyno.2006.05.047 1:CAS:528:DC%2BD28Xht1KgtLfL (Pubitemid 44821316)
7. K Sonoda S Miyamoto T Hirakawa H Yagi F Yotsumoto M Nakashima T Watanabe H Nakano 2005 Invasive potency related to RCAS1 expression in uterine cervical cancer Gynecol Oncol 99 189 198 16112176 10.1016/j.ygyno.2005.06.061 1:CAS:528:DC%2BD2MXhtVartrjM (Pubitemid 41354601)
8. K Sonoda S Miyamoto H Kobayashi S Ogawa K Okugawa S Taniguchi N Wake 2009 The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer Int J Gynecol Cancer 19 838 843 19574770 10.1111/IGC.0b013e3181a5ff6a
9. MI Kokkinos R Wafai MK Wong DF Newgreen EW Thompson M Waltham 2007 Vimentin and epithelial-mesenchymal transition in human breast cancer - observations in vitro and in vivo Cells Tissues Organs 185 191 203 17587825 10.1159/000101320 1:CAS:528:DC%2BD2sXmvFSnu70%3D (Pubitemid 46957486)
10. M Dutsch-Wicherek R Tomaszewska A Lazar Ł Wicherek J Skladzień 2009 The association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse BMC Cancer 9 35 19175908 10.1186/1471-2407-9-35
11. M Dutsch-Wicherek 2010 RCAS1, MT, and vimentin as potential markers of tumor microenvironment remodeling Am J Reprod Immunol 63 181 188 20085563 10.1111/j.1600-0897.2009.00803.x 1:CAS:528:DC%2BC3cXjvVKks7k%3D
12. S Tsujitani H Saito S Oka T Sakamoto S Kanaji S Tatebe M Ikeguchi 2002 Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma Dig Dis Sci 52 549 554 10.1007/s10620-006-9408-6
13. K Fukuda S Tsujitani Y Maeta K Yamaguchi M Ikeguchi N Kaibara 2002 The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma Gastric Cancer 5 220 227 12491080 10.1007/s101200200038 1:CAS:528:DC%2BD38XpsFOmtbw%3D (Pubitemid 36605885)
14. Y Nakamura K Yamazaki S Oizumi M Nakashima T Watanabe H Dosaka-Akita M Nishimura 2004 Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape Cancer Sci 95 260 265 15016327 10.1111/j.1349-7006. 2004.tb02213.x 1:CAS:528:DC%2BD2cXjs1ymu70%3D (Pubitemid 38489094)
15. T Oshikiri Y Hida M Miyamoto H Hashida K Katoh M Suzuoki Y Nakakubo K Hiraoka T Shinohara T Itoh S Kondo H Katoh 2001 RCAS1 as a tumor progression marker: an independent negative prognostic factor in gallbladder cancer Br J Cancer 85 1922 1927 11747335 10.1054/bjoc.2001.2192 1:CAS:528: DC%2BD38XhsVWnu7w%3D (Pubitemid 34775330)
16. K Hiraoka Y Hida M Miyamoto T Oshikiri M Suzuoki Y Nakakubo T Shinohara T Itoh T Shichinohe S Kondo N Kasahara H Katoh 2002 High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker Int J Cancer 99 418 423 11992411 10.1002/ijc.10381 1:CAS:528:DC%2BD38XjsFagtbs%3D (Pubitemid 34495856)
17. T Okada T Iiai Y Kawachi T Moroda Y Takii K Hatakeyama T Abo 1995 Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer Clin Exp Immunol 102 159 166 7554383 10.1111/j.1365-2249.1995.tb06650.x 1:STN:280:DyaK28%2Fgtl2ltw%3D%3D
18. A Mantovani P Allavena A Sica F Balkwill 2008 Cancer-related inflammation Nature 454 436 444 18650914 10.1038/nature07205 1:CAS:528:DC%2BD1cXovV2mtbg%3D
19. K Sonoda S Miyamoto F Yotsumoto H Yagi M Nakashima T Watanabe H Nakano 2007 Clinical significance of RCAS1 as a biomarker of ovarian cancer Oncol Rep 17 623 628 17273743 1:CAS:528:DC%2BD2sXivF2gsro%3D
20. M Dutsch-Wicherek L Wicherek 2008 The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas Am J Reprod Immunol 59 266 275 18275520 10.1111/j.1600-0897. 2007.00575.x (Pubitemid 351250427)
21. Ł Wicherek M Dutsch P Mak M Klimek J Skladzien A Dubin 2003 Comparative analysis of RCAS1 level in neoplasms and placenta Acta Biochim Pol 50 1187 1194 14740005 1:CAS:528:DC%2BD2cXhtFGktLg%3D (Pubitemid 38608846)
22. T Akashi H Oimomi K Nishiyama M Nakashima Y Arita T Sumii T Kimura T Ito H Nawata T Watanabe 2003 Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer Pancreas 26 49 55 12499917 10.1097/00006676-200301000-00009 1:CAS:528:DC%2BD3sXns1SntL0%3D (Pubitemid 36020266)
23. L Wicherek 2009 Alterations in RCAS1 serum concentration levels during menstrual cycle in patients with uterine leiomyoma and lack of analogical changes in adenomyosis Gynecol Obstet Investig 67 195 201 10.1159/000188045 1:CAS:528:DC%2BD1MXltFWhurg%3D
24. S Coban H Ozkan S Köklü O Yüksel MC Koçkar T Akar N Ormeci 2006 The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers Can J Gastroenterol 20 593 596 17001401 (Pubitemid 44596402)
25. TA Waldmann 1993 The IL-2/IL-2 receptor system: a target for rational immune intervention Immunol Today 14 264 270 8397768 10.1016/0167-5699(93)90043- K 1:CAS:528:DyaK3sXltlKqtrs%3D (Pubitemid 23186988)
26. CN Baxevanis GV Dedoussis NG Papadopoulos I Missitzis GP Stathopoulos M Papamichail 1994 Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer Cancer 74 1275 1282 7914469 10.1002/1097-0142(19940815)74: 4<1275::AID-CNCR2820740416>3.0.CO;2-Q 1:STN:280:DyaK2czjt1Okuw%3D%3D (Pubitemid 24301780)
27. G Parmiani A Anichini G Fossati 1990 Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? J Natl Cancer Inst 82 361 370 2406452 10.1093/jnci/82.5.361 1:STN:280:DyaK3c7ls1Cjsw%3D%3D (Pubitemid 20108026)
28. G Parmiani 1990 An explanation of the variable clinical response to interleukin 2 and LAK cells Immunol Today 11 113 115 2187466 10.1016/0167-5699(90)90046-C 1:CAS:528:DyaK3cXkvFGruro%3D (Pubitemid 20095093)
29. BJ Coventry SC Weeks SE Heckford PJ Sykes J Bradley JM Skinner 1996 Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers J Immunol 156 3486 3492 8617977 1:CAS:528:DyaK28XisFaqt74%3D (Pubitemid 26123565)
30. S Miescher TL Whiteside L Moretta V Von Fliedner 1987 Clonal and frequency analyses of tumor infiltrating T lymphocytes from human solid tumors J Immunol 138 4004 4011 3108380 1:STN:280:DyaL2s3isVSmtg%3D%3D (Pubitemid 17078287)
31. BC Sheu RH Lin HN Ho SC Huang 1997 Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma Hum Immunol 56 39 48 9455492 10.1016/S0198-8859(97)00111-0 1:STN:280:DyaK1c7hs1Kksg%3D%3D (Pubitemid 28018598)
32. J Wyckoff W Wang EY Lin Y Wang F Pixley ER Stanley T Graf JW Pollard J Segall J Condeelis 2004 A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors Cancer Res 64 7022 7029 15466195 10.1158/0008-5472.CAN-04-1449 1:CAS:528:DC%2BD2cXotFalsLg%3D (Pubitemid 39331012)
33. JW Pollard 2004 Tumor-educated macrophages promote tumor progression and metastasis Nat Rev Cancer 4 71 78 14708027 10.1038/nrc1256 1:CAS:528: DC%2BD2cXos12qtA%3D%3D (Pubitemid 38082155)
34. J Vakkila MT Lotze 2004 Inflammation and necrosis promote tumor growth Nat Rev Immunol 4 641 648 15286730 10.1038/nri1415 1:CAS:528: DC%2BD2cXmtFWktrg%3D (Pubitemid 39025049)
35. A Mantovani S Sozzani M Locati P Allavena A Sica 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 549 555 12401408 10.1016/S1471-4906(02) 02302-5 1:CAS:528:DC%2BD38XotVKktrc%3D (Pubitemid 35223554)
36. A Mantovani T Schioppa C Porta P Allavena A Sica 2006 Role of tumor-associated macrophages in tumor progression and invasion Cancer Metastasis Rev 25 315 322 16967326 10.1007/s10555-006-9001-7 (Pubitemid 44922352)
37. B Bottazzi N Polentarutti R Acero A Balsari D Boraschi P Ghezzi M Salmona A Mantovani 1983 Regulation of the macrophage content of neoplasms by chemoattractans Science 220 210 212 6828888 10.1126/science.6828888 1:CAS:528:DyaL3sXhvFKhtr0%3D (Pubitemid 13115270)
38. P Polverini SJ Leibovich 1984 Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages Lab Invest 51 635 642 6209469 1:STN:280:DyaL2M%2FlvFamtA%3D%3D (Pubitemid 15182529)
39. Y Suehiro K Muta M Nakashima Y Abe M Shiratsuchi S Shiokawa S Ikuyama Y Yoshikawa T Watanabe J Nishimura 2005 A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1 Eur J Haematol 74 365 373 15813909 10.1111/j.1600-0609.2004.00389.x 1:CAS:528:DC%2BD2MXktlent7g%3D (Pubitemid 40545560)
40. T Matsushima M Nakashima K Oshima Y Abe J Nishimura H Nawata T Watanabe K Muta 2001 Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells Blood 15 313 321 10.1182/blood.V98.2.313
41. M Enjoji 2006 RCAS1-expressing macrophages in inflammatory liver diseases Liver Int 26 385 387 16584404 10.1111/j.1478-3231.2005.01223.x (Pubitemid 43349332)
42. M Dutsch-Wicherek R Tomaszewska P Strȩk Ł Wicherek J Składzień 2006 The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration BMC Immunol 7 4 16551346 10.1186/1471-2172-7-4
43. M Dutsch-Wicherek R Tomaszewska A Lazar P Strek Ł Wicherek K Piekutowski W Jóźwicki 2010 The evaluation of metallothionein expression in nasal polyps with respect to immune cell presence and activity BMC Immunol 11 10 20214821 10.1186/1471-2172-11-10
44. TL Whiteside 2010 Immune responses to malignancies J Allergy Clin Immunol 125 S272 S283 20061007 10.1016/j.jaci.2009.09.045
45. KL Knutson ML Disis LG Salazar 2007 CD4 regulatory cells in human cancer pathogenesis Cancer Immunol Immunother 56 271 285 16819631 10.1007/s00262-006- 0194-y (Pubitemid 46035899)